tiprankstipranks
Trending News
More News >
Kaleido Biosciences Inc (KLDO)
OTHER OTC:KLDO
US Market

Kaleido Biosciences (KLDO) Income Statement

Compare
198 Followers

Kaleido Biosciences Income Statement

Last quarter (Q4 2021), Kaleido Biosciences's total revenue was $492.00K, an increase of 102.47% from the same quarter last year. In Q4, Kaleido Biosciences's net income was $-21.12M. See Kaleido Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.10M$ 975.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.25M$ -54.99M$ -1.32M$ 0.00$ 0.00
Operating Expenses
$ 86.41M$ 23.88M$ 86.66M$ 60.68M$ 27.03M
Depreciation and Amortization
$ 2.58M$ 1.82M$ 1.32M$ 792.00K$ 316.00K
EBITDA
$ -85.09M$ -77.00M$ -84.04M$ -59.03M$ -26.70M
Operating Income
$ -87.67M$ -78.87M$ -86.66M$ -60.68M$ -27.03M
Other Income/Expenses
$ -2.62M$ -2.75M$ 329.00K$ -1.06M$ -529.00K
Pretax Income
$ -90.29M$ -81.62M$ -86.33M$ -61.74M$ -27.56M
Net Income
$ -90.29M$ -81.62M$ -85.01M$ -61.74M$ -27.56M
Per Share Metrics
Basic EPS
$ -2.16$ -2.44$ -3.31$ -2.10$ -1.23
Diluted EPS
$ -2.16$ -2.44$ -3.31$ -2.10$ -1.23
Weighted Average Shares Outstanding
41.86M 33.45M 25.70M 29.39M 22.42M
Weighted Average Shares Outstanding (Diluted)
41.86M 33.45M 25.70M 29.39M 22.42M
Currency in USD

Kaleido Biosciences Earnings and Revenue History